<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0"><channel><title>VACCINE</title><link>https://www.spreaker.com/podcast/vaccine--3598165</link><description><![CDATA[]]></description><atom:link href="https://www.spreaker.com/show/3598165/episodes/feed" rel="self" type="application/rss+xml"/><language>en</language><category>Life Sciences</category><copyright>Copyright echo han</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/nuvolari-assets/blue_square_mic.jpg</url><title>VACCINE</title><link>https://www.spreaker.com/podcast/vaccine--3598165</link></image><lastBuildDate>Fri, 02 Jul 2021 06:52:53 +0000</lastBuildDate><itunes:author>echo han</itunes:author><itunes:owner><itunes:name>echo han</itunes:name><itunes:email>feeds@spreaker.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/nuvolari-assets/blue_square_mic.jpg"/><itunes:category text="Science"><itunes:category text="Life Sciences"/></itunes:category><itunes:explicit>false</itunes:explicit><podcast:guid>8b518cbc-20ef-5230-89c6-abc7a5132473</podcast:guid><itunes:type>episodic</itunes:type><item><title>Vaccine Development &amp; GMP Manufacturing</title><link>https://www.spreaker.com/episode/vaccine-development-gmp-manufacturing--45540388</link><description><![CDATA[The analytical testing of vaccines provides evidence that the vaccine and its intermediates meet the specifications defined within the BLA.<a href="https://www.creative-biolabs.com/vaccine/vaccine-analytical-development-qualification.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/vaccine-analytical-development-qualification.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540388</guid><pubDate>Fri, 02 Jul 2021 06:52:53 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540388/vaccine_development_gmp_manufacturing_creative_biolabs.mp3" length="8299229" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>The analytical testing of vaccines provides evidence that the vaccine and its intermediates meet the specifications defined within the BLA.https://www.creative-biolabs.com/vaccine/vaccine-analytical-development-qualification.htm</itunes:subtitle><itunes:summary><![CDATA[The analytical testing of vaccines provides evidence that the vaccine and its intermediates meet the specifications defined within the BLA.<a href="https://www.creative-biolabs.com/vaccine/vaccine-analytical-development-qualification.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/vaccine-analytical-development-qualification.htm</a>]]></itunes:summary><itunes:duration>519</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/nuvolari-assets/blue_square_mic.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Nano Adjuvant</title><link>https://www.spreaker.com/episode/nano-adjuvant--45540387</link><description><![CDATA[Nanotechnology is increasingly important in vaccine development. As vaccines are evolving toward less immunogenic minimalist compositions, adjuvants and delivery systems that increase the effectiveness of the antigen are of increasing importance. <a href="https://www.creative-biolabs.com/vaccine/nanoparticles.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/nanoparticles.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540387</guid><pubDate>Fri, 02 Jul 2021 06:51:47 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540387/nano_adjuvant_creative_biolabs.mp3" length="10015370" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>Nanotechnology is increasingly important in vaccine development. As vaccines are evolving toward less immunogenic minimalist compositions, adjuvants and delivery systems that increase the effectiveness of the antigen are of increasing importance....</itunes:subtitle><itunes:summary><![CDATA[Nanotechnology is increasingly important in vaccine development. As vaccines are evolving toward less immunogenic minimalist compositions, adjuvants and delivery systems that increase the effectiveness of the antigen are of increasing importance. <a href="https://www.creative-biolabs.com/vaccine/nanoparticles.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/nanoparticles.htm</a>]]></itunes:summary><itunes:duration>626</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/nuvolari-assets/blue_square_mic.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>mRNA Vaccine</title><link>https://www.spreaker.com/episode/mrna-vaccine--45540386</link><description><![CDATA[RNA vaccines can be divided into traditional mRNA-based vaccines and self-amplifying mRNA (SAM) vaccines. Their basic principle is to use the host cell's transcription system to produce target antigens to stimulate adaptive immunity.<a href="https://www.creative-biolabs.com/vaccine/self-amplifying-mrna-sam-vaccine-platform.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/self-amplifying-mrna-sam-vaccine-platform.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540386</guid><pubDate>Fri, 02 Jul 2021 06:50:58 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540386/mrna_vaccine_creative_biolabs_202012.mp3" length="11116538" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>RNA vaccines can be divided into traditional mRNA-based vaccines and self-amplifying mRNA (SAM) vaccines. Their basic principle is to use the host cell's transcription system to produce target antigens to stimulate adaptive...</itunes:subtitle><itunes:summary><![CDATA[RNA vaccines can be divided into traditional mRNA-based vaccines and self-amplifying mRNA (SAM) vaccines. Their basic principle is to use the host cell's transcription system to produce target antigens to stimulate adaptive immunity.<a href="https://www.creative-biolabs.com/vaccine/self-amplifying-mrna-sam-vaccine-platform.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/self-amplifying-mrna-sam-vaccine-platform.htm</a>]]></itunes:summary><itunes:duration>695</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/nuvolari-assets/blue_square_mic.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>HIV vaccine</title><link>https://www.spreaker.com/episode/hiv-vaccine--45540382</link><description><![CDATA[E-Vaccines Platform for HIV<br /><a href="https://www.creative-biolabs.com/vaccine/electrophilic-vaccines-e-vaccines-platform-for-hiv.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/electrophilic-vaccines-e-vaccines-platform-for-hiv.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540382</guid><pubDate>Fri, 02 Jul 2021 06:50:08 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540382/hiv_vaccine_creative_biolabs.mp3" length="11897440" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>E-Vaccines Platform for HIV
https://www.creative-biolabs.com/vaccine/electrophilic-vaccines-e-vaccines-platform-for-hiv.htm</itunes:subtitle><itunes:summary><![CDATA[E-Vaccines Platform for HIV<br /><a href="https://www.creative-biolabs.com/vaccine/electrophilic-vaccines-e-vaccines-platform-for-hiv.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/electrophilic-vaccines-e-vaccines-platform-for-hiv.htm</a>]]></itunes:summary><itunes:duration>744</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/nuvolari-assets/blue_square_mic.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>HBV Vaccine</title><link>https://www.spreaker.com/episode/hbv-vaccine--45540381</link><description><![CDATA[The woodchuck hepatitis virus (WHV) can be used as an animal model for pathogenesis and therapy of chronic hepatitis B virus (HBV) infection and human disease.<a href="https://www.creative-biolabs.com/vaccine/woodchuck-model-for-hbv-vaccine-development.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/woodchuck-model-for-hbv-vaccine-development.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540381</guid><pubDate>Fri, 02 Jul 2021 06:49:01 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540381/hbv_vaccine_creative_biolabs.mp3" length="9476202" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>The woodchuck hepatitis virus (WHV) can be used as an animal model for pathogenesis and therapy of chronic hepatitis B virus (HBV) infection and human disease.https://www.creative-biolabs.com/vaccine/woodchuck-model-for-hbv-vaccine-development.htm</itunes:subtitle><itunes:summary><![CDATA[The woodchuck hepatitis virus (WHV) can be used as an animal model for pathogenesis and therapy of chronic hepatitis B virus (HBV) infection and human disease.<a href="https://www.creative-biolabs.com/vaccine/woodchuck-model-for-hbv-vaccine-development.htm" rel="noopener">https://www.creative-biolabs.com/vaccine/woodchuck-model-for-hbv-vaccine-development.htm</a>]]></itunes:summary><itunes:duration>593</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/nuvolari-assets/blue_square_mic.jpg"/><itunes:episodeType>full</itunes:episodeType></item></channel></rss>
